# LOSS- Louisiana Obese Subjects Study

> **NCT00115063** · PHASE4 · TERMINATED · sponsor: **Pennington Biomedical Research Center** · enrollment: 390 (actual)

## Conditions studied

- Obesity

## Interventions

- **BEHAVIORAL:** group sessions
- **DRUG:** sibutramine, orlistat, diethylpropion
- **BEHAVIORAL:** Low Calorie Diet, Health One
- **OTHER:** Intensive Medical Combination Therapy for Obesity
- **OTHER:** Control Condition

## Key facts

- **NCT ID:** NCT00115063
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 390 (ACTUAL)
- **Why stopped:** ethical issues of continuing control group without treatment
- **Last updated:** 2016-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115063, "LOSS- Louisiana Obese Subjects Study". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00115063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*